Scientists test if new baby RSV vaccine can spread to others
NCT ID NCT05687279
Summary
This study tested a new nasal spray vaccine designed to protect infants and toddlers from Respiratory Syncytial Virus (RSV). Researchers gave the vaccine to 80 healthy children aged 6 to 24 months in Puerto Rico to see if the weakened virus in the vaccine could spread to other children in their household or daycare. The main goals were to check if the vaccine virus spread, how long it stayed in the nose, and if it remained stable, while also monitoring safety and immune responses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number : 6300001
San Juan, 00918, Puerto Rico
-
Investigational Site Number : 6300002
Carolina, 984, Puerto Rico
-
Investigational Site Number : 6300003
Guayama, 00784, Puerto Rico
-
Investigational Site Number : 6300004
Bayamón, 00960, Puerto Rico
-
Meridian Clinical Research Norfolk Site Number : 8400003
Norfolk, Nebraska, 68701, United States
-
Velocity Clinical Research, Omaha Site Number : 8400001
Omaha, Nebraska, 68134, United States
Conditions
Explore the condition pages connected to this study.